Introduction {#s1}
============

The COMMD (Copper Metabolism Murr1 (Mouse U2af1-rs1 region 1) Domain) proteins are highly conserved in metazoans and unicellular protozoa ([@bib10]; [@bib35]). There are ten family members that play key roles in intracellular trafficking and in the regulation of transcription ([@bib10]; [@bib35]). A hallmark of the COMMD family members is a highly conserved C-terminal sequence of \~70--80 amino acids called the COMM domain, which has no known structure. The N-terminal domain of these proteins, which we refer to as the HN (helical N-terminal) domain, is more variable in sequence across the ten proteins, and is proposed to ascribe unique functions to the different family members ([@bib10]; [@bib35]). Despite the high degree of conservation and the important roles of COMMD proteins in membrane trafficking and cell signalling, little is known about their structures or their specific molecular functions.

In humans, all ten members of the COMMD family (Commd1-Commd10) are expressed broadly in many tissues ([@bib10]; [@bib62]). Much of our current understanding of the COMMD proteins is derived from studies of the founding family member Commd1. An in-frame deletion in exon 2 of the *COMMD1* gene was first identified in Bedlington terrier dogs with hepatic copper toxicosis ([@bib62]; [@bib56]). In accordance with the link of Commd1 to copper metabolism, it was reported to bind to Cu(II), implying that COMMD family members might serve as metal binding proteins ([@bib44]), although this was questioned by subsequent studies. Commd1 has also been shown to associate with both ATP7A and ATP7B and is thought to mediate their trafficking from endosomes to the plasma membrane ([@bib40]). In humans, ATP7A and ATP7B are responsible for controlling intracellular Cu(II) accumulation ([@bib56]; [@bib40]; [@bib65]; [@bib43]; [@bib47]) and are involved in conditions related to copper toxicity including Wilson's disease ([@bib67]), suggesting an alternative role for Commd1 in copper homeostasis. In line with a more general function in intracellular trafficking, Commd1 depletion causes a marked reduction in surface levels of low-density lipoprotein receptor (LDLR), with increased endosomal accumulation leading to a concomitant increase in cholesterol levels ([@bib5]). Although COMMD proteins are expected to be structurally similar, there may be non-redundant trafficking roles mediated by different members of the family. For example, Commd9 is deleted in patients with Wilms tumour-aniridia syndrome (WAGR) syndrome, and appears to interact specifically with Notch2 to regulate its surface abundance by shuttling the receptor away from the lysosomal degradative pathway ([@bib32]). Members of the COMMD family have also been linked to nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcriptional regulation, hypoxia adaptation, and regulation of intracellular sodium concentration via interactions with the epithelial sodium channels (ENaCs) ([@bib12]; [@bib33]; [@bib37]).

COMMD proteins have been found to exist in an endosome-associated complex with the coiled-coil domain-containing proteins CCDC22 and CCDC93, which has been termed the CCC (COMMD, CCDC22, CCDC93) complex. In addition, functional proteomics and bioinformatics have independently shown that the CCC complex can associate with a stable heterotrimeric assembly of VPS29, C16orf62 and DSCR3, to form a larger macromolecular complex dubbed the 'Commander' or CCC/Retreiver complex ([@bib38]; [@bib66]; [@bib41]). Other proteins such as SNX17, RanBP1, SH3GLB1 and FAM45a are also thought to associate with the Commander complex ([@bib66]; [@bib13]; [@bib25]; [@bib29]). Further complexity arises from evidence that COMMD proteins can form homo- and heterodimers through their COMM domains ([@bib10]). Although Commd9 and Commd5 associate directly with each other ([@bib66]), it remains unclear whether the COMMD proteins interact physically with each other more generally, or how this relates to their assembly with CCDC22 and CCDC93 in CCC and the larger Commander complex.

In this study we provide a comprehensive and systematic analysis of the structural, biophysical and biochemical properties of the COMMD family of proteins, and their recruitment to the CCC complex. These analyses show that COMMD proteins form family-wide homo- and heterodimers through their C-terminal COMM domains. The crystal structure of the COMM domain from Commd9 reveals an intimately interlocked α/β homodimeric structure, which involves formation of a large and conserved hydrophobic interface. The crystal structure of the N-terminal domain of Commd9 shows an all α-helical structure, and using small angle X-ray scattering we establish that homodimers of full-length Commd1, Commd7 and Commd9 adopt similar tertiary architectures. Intriguingly, the COMMD proteins show clear structural homology to a poorly characterised protein found in chlamydial species of bacteria. Further biochemical studies show that C-terminal COMM domains have pleiotropic roles in both recruitment of CCDC22 and CCDC93 via their N-terminal calponin homology-like (NN-CH) domains, and in binding non-specifically to negatively charged phospholipids.

Results {#s2}
=======

COMMD proteins form homodimers via the C-terminal COMM domain {#s2-1}
-------------------------------------------------------------

As a first step towards assessing the self-assembly activities of COMMD proteins, we studied the biophysical properties of recombinant full-length COMMD proteins in solution. Of all COMMD proteins we tested Commd1, Commd7 and Commd9 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) were readily purified and tractable for biophysical analyses. We measured their molecular weights by analytical size exclusion chromatography coupled with multi-angle laser light scattering (SEC-MALLS). This showed that Commd1, Commd7 and Commd9 form homodimers and are monodisperse in solution ([Figure 1A,B](#fig1){ref-type="fig"}). SEC-MALLS data suggests that dimerization is likely to be a general property of the COMMD family members. To determine the domains required for homodimerisation we performed SEC-MALLS analyses of isolated HN and COMM domains. While the Commd1 and Commd9 HN domains behave as monomers, Commd1 and Commd9 COMM domains exist as dimeric species ([Figure 1B,C](#fig1){ref-type="fig"}). This data shows that the COMM domain is both required and sufficient to mediate COMMD protein dimerization.

![COMMD proteins dimerize through the C-terminal COMM domain.\
(**A**) Cartoon representation of COMMD proteins, and the MALLS profile of Commd1 (black), Commd7 (red) and Commd9 (blue) showing Commd proteins are dimers in solution (**B**) Comparison of the theoretical molecular weight of the COMMD proteins and the experimentally measured molecular weight. (**C**) MALLS analyses of the COMM and HN domain shows that the protein dimerisation occurs through the C-terminal COMM domain of the COMMD proteins as represented schematically. (**D**) Ribbon representation of the dimeric Commd9 COMM domain (residues 115--198) chain A (yellow) and chain B (blue). (**E**) The structure of the COMM domain dimer is analogous in orientation to a left-handed handshake.](elife-35898-fig1){#fig1}

Structural analysis of the COMMD proteins {#s2-2}
-----------------------------------------

We next sought to determine the X-ray crystallographic structures of COMMD proteins. However, although crystals of various full-length COMMD proteins grew rapidly, their diffraction quality was not sufficient for structure determination. Therefore a divide-and-conquer approach was taken to determine structures of the two individual domains of the protein, the conserved C-terminal COMM domain, and the variable N-terminal HN domain.

Crystal structure of the Commd9 C-terminal COMM domain {#s2-3}
------------------------------------------------------

We determined the crystal structure of the Commd9 COMM domain to 2.2 Å resolution by single-wavelength anomalous dispersion (SAD). The overall structure of the Commd9 COMM domain is composed of two cone-shaped chains that are tightly intertwined with each other to form a globular dimeric module ([Figure 1D](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). Each monomer is comprised of an N-terminal three-stranded β-sheet capped by an α-helix, with the overall arrangement making an open, hairpin-like structure. A simple analogy for the COMM domain dimer is that it resembles a left-handed handshake, where the sheet and helix from each monomer represent the interlocked palms and thumbs of each hand respectively ([Figure 1E](#fig1){ref-type="fig"}). The overlapping C-terminal α-helices of each chain bury a large hydrophobic surface area of approximately 2100 Å^2^ (nearly 1/3^rd^ of the monomer surface area) supporting the notion that the native state of COMMD proteins is to form dimers via the COMM domain.
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###### Summary of crystallographic structure determination statistics.\*

                                                                 Commd9 HN domain (1--117)   Commd9 COMM domain (115--198)
  ------------------------------------- ------------------------ --------------------------- -------------------------------
  Data collection                                                                            
  Space group                           P 1                      I 4                         
  28.5 Å, 35.6 Å, 54.3 Å;               79.4 Å, 79.4 Å, 58.5 Å                               
  Unit cell dimensions (a,b,c; α,β,γ)   104.0°, 93.3°, 91.1°     90°, 90°, 90°               
                                        Remote                   Inflection                  
  Wavelength (Å)                        0.9762                   0.9796                      0.9787
  Total reflections                     172817                   146841                      131332
  Resolution range (Å)                  19--84 -- 1.55 (1.58)    19--84 -- 1.55 (1.58)       47.13--2.17 (2.24)
  Mean I/sigma(I)                       16.9 (5.2)               25.2 (9.3)                  26.7 (4.9)
  R-merge                               0.10 (0.54)              0.06 (0.18)                 0.06 (0.5)
  Unique reflections                    27698                    27442                       9689
  Multiplicity                          6.2 (6.0)                5.4 (5.3)                   13.6 (11.8)
  Anomalous Multiplicity                3.1 (3.1)                2.6 (2.7)                   6.9 (6.1)
  Mn(I) half-set correlation CC(1/2)    0.99 (0.89)              0.99 (0.98)                 0.99 (0.95)
  Completeness (%)                      91.9 (54.9)              91.0 (52.7)                 99.7 (96.4)
  Anomalous Completeness (%)            89.6 (50.3)              88.1 (48.1)                 99.3 (93.0)
  Wilson B-factor                       8.4                      18.6                        53.1
  Refinement                                                                                 
  R-work                                                         0.13 (0.25)                 0.24 (0.30)
  R-free                                                         0.16 (0.33)                 0.28 (0.35)
  Resolution range (Å)                                           26.28--1.55                 30.36--2.17
  Number of atoms                                                2078                        1268
  Protein atoms                                                  1784                        1259
  RMS(bonds)                                                     0.009                       0.002
  RMS(angles)                                                    1.158                       0.549
  Ramachandran favored (%)                                       100                         98.06
  Ramachandran outliers (%)                                      0                           0
  Average B-factor                                               13.11                       85.61

\*Highest resolution shell is shown in parentheses.

COMMD proteins dimerise via a conserved hydrophobic interface in the COMM domain {#s2-4}
--------------------------------------------------------------------------------

In [Figure 2](#fig2){ref-type="fig"} the interface that mediates Commd9 dimerisation is examined in closer detail. Using CONSURF ([@bib2]; [@bib31]), the most evolutionarily conserved residues in Commd9 were mapped onto the structure. There is a very high degree of sequence conservation seen in the hydrophobic core of the Commd9 COMM domain, particularly along the α-helical surface mediating dimerisation ([Figure 2A](#fig2){ref-type="fig"}). Multiple sequence alignment of the COMM domains of all the COMMD proteins demonstrates conservation of many hydrophobic amino acids, particularly leucine residues ([Figure 2B](#fig2){ref-type="fig"}). The high degree of conservation, and high degree of hydrophobicity within the dimerization interface strongly suggests that all of the COMMD proteins will form obligatory dimeric structures through similar mechanisms. We attempted to mutate several interfacial residues, but both the full-length mutated COMMD proteins and isolated COMM domains were aggregated due to poor protein solubility (not shown). This provides further support for the essential nature of dimer formation.

![Structural mechanism underpinning the COMMD dimerization.\
(**A**) A surface map of the conserved and variable residues of the Commd9 COMM domain showing the hydrophobic core is highly conserved while the surface residues are more variable, confirming the importance of dimerization for COMMD stability. These calculations are made using the Consurf server ([@bib3]) on chain A. (**B**) A combined sequence alignment and secondary structure comparison of COMM domains of all the human COMMD proteins highlights that the C-terminal COMM domain is highly conserved across the COMMD family of proteins. Residues marked by asterisk depict conservation of amino acids that decorate the dimerization interface. Alignments were made with ESPript 2.2 (<http://espript.ibcp.fr/ESPript/ESPript/>) ([@bib23]) (**C**) Representation of dimer interface of Commd9 COMM domain highlighting key residues (chain A, worm in blue) making main chain-main chain, stacking, salt bridge interactions with the electrostatic surface (chain B).](elife-35898-fig2){#fig2}

Crystal structure of the Commd9 N-terminal HN domain {#s2-5}
----------------------------------------------------

We next determined the structure of the Commd9 N-terminal domain by X-ray crystallography to a resolution of 1.55 Å using multi-wavelength anomalous dispersion. Overall, the Commd9 N-terminal domain has a globular architecture and is composed of a six-helix bundle with a meander topology ([Figure 3A](#fig3){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). We therefore refer to this domain as the HN (*H*elical *N*-terminal) domain. The overall structure of the HN domain has a similar all α-helical fold to the equivalent domain of Commd1, which was previously determined by NMR ([Figure 3B](#fig3){ref-type="fig"}) ([@bib51]). Compared to Commd1 however, the HN domain of Commd9 has an additional α-helix at its N-terminus that packs down on top of the structure, and a large disordered loop in Commd1 is better resolved in Commd9. In Commd9 the α4 helix forms a central core element that extends the length of the HN domain. In Commd1 however, the equivalent helix is bent and oriented differently. This could be due to the absence of the α1 helix to provide stability, or might also be due to an insufficient number of restraints in this region used for NMR structure calculations. However, the topology of the five shared α-helices (α2-α6) is similar overall. Comparing the HN domains of Commd1 and Commd9 using DALI ([@bib27]; [@bib28]) showed structural similarity (DALI Z-score \>3) with an RMSD of 3.2 Å over 83 Cα atoms.

![Structure of the N-terminal HN domain of Commd9.\
(**A**) Cartoon representation of Commd9 HN domain (1--116) crystal structure crystallized at pH 4.9 showing a globular structure. (**B**) NMR structure of the Commd1 HN domain (PDB ID 2H2M) ([@bib51]) shown in cartoon diagram in the same orientation as Commd9 in [Figure 3A](#fig3){ref-type="fig"} left panel. The Commd1 HN domain lacks the first helix (α1) and appears to have a kinked helix α4, but overall shares the same topology. (**C**) Sequence conservation of Commd9 HN domain mapped on the structure using CONSURF.](elife-35898-fig3){#fig3}

The electrostatic surface of the Commd9 HN domain reveals the presence of two basic patches and a negatively charged region, but it is not clear yet what their functional significance might be ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Mapping sequence conservation of the Commd9 HN domain across species shows conserved surface residues mainly in the α1 helix region ([Figure 3C](#fig3){ref-type="fig"}). The N-terminal regions of the COMMD proteins are quite variable in sequence across the ten family members (although they are well conserved in paralogous proteins across species), and this has led to it being referred to as a variable domain or VARD ([@bib35]). Bioinformatics and secondary structure analyses of the human COMMD proteins however, shows that in all of the family members the HN domain is very likely to share the same α-helical topology, as well as across various species of Commd9 ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}). In support of this, the HN domain of human Commd3 shows a strong α--helical l signal when examined using far-UV circular dichroism spectroscopy (not shown). The exception to this is human Commd6, which does not possess an HN domain at all, although Commd6 orthologs in other species such as fish and amphibians do ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}).

Solution structures of COMMD proteins reveal a conserved homodimeric structure {#s2-6}
------------------------------------------------------------------------------

In the absence of high-resolution crystal structures of full-length COMMD proteins, we employed SEC-SAXS to obtain solution structural information regarding the architectures of homodimeric Commd1, Commd7 and Commd9 proteins ([Figure 4](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}; [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}; [Table 2](#table2){ref-type="table"}). The scattering curves and pair distribution functions (*P(r)*s) both signify a relatively globular structure. *Ab initio* structures of these calculated from the SAXS data reveal compact but elongated molecules. We next performed rigid body fitting of the SAXS data with the program SASREF ([@bib46]), using the crystal structures of the Commd9 HN and COMM domains for Commd7 and Commd9 whereas Commd1 HN and Commd9 COMMD domain was used for generating the Commd1 model. The resulting models obtained by this approach were superimposed on the SAXS envelope. The theoretical scattering profiles of Commd1, Commd7 and Commd9 models, and the *ab initio* molecular envelopes are in good agreement with the experimental scattering data with low χ^2^ values. These studies suggest that the COMMD proteins, including Commd9 are homodimers with an elongated shape in solution.

![The solution structure of Commd9 determined by SAXS.\
(**A**) (Left) Experimental scattering profile Commd9 in black overlaid with the theoretical scattering curve calculated from the Commd9 rigid body model (red) and the *ab initio* model determined by GASBOR (green) using CRYSOL. (Middle) The Guinier plot for the experimental data at the low-angle region (q~max~ × R~g~ \< 1.3). (Right) P~(r)~ functions derived from the SAXS data. (**B**) (Left) Averaged (grey) and filtered (coral) molecular envelopes from GASBOR. The *ab initio* model of Commd9 was docked with the rigid body model of Commd9 using SUPCOMB. (Right) Model of Commd9 protein from the experimental SAXS shown in ribbon diagram with HN domains in grey and the COMM domain dimer in blue and yellow.](elife-35898-fig4){#fig4}
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###### Summary of SAXS structural parameters.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                Commd1                                          Commd7                          Commd9
  --------------------------------------------- ----------------------------------------------- ------------------------------- -------------------------------
  Data collection parameters                                                                                                    

  Instrument                                    Australian Synchrotron SAXS/WAXS beamline\                                      
                                                with Dectris PILATUS 1M detector                                                

  Wavelength (Å)                                1.0332                                                                          

  Beam geometry (μM)                            250 × 130                                                                       

  Camera length (m)                             1.6                                                                             

  *q*-range (Å^−1^)                             0.011--0.251                                                                    

  Absolute scaling method                       Comparision with scattering from 1 mm H2O                                       

  Normalization                                 To transmitted intensity by beam-stop counter                                   

  Method for monitoring radiation damage        Dose maintained below 210 Gy                                                    

  Exposure per frame (s)                        1                                                                               

  Sample temperature (K)                        283                                                                             

  Sample configuration                          SEC-SAXS with sheath-flow cell                                                  

  Flow-rate (ml/min)                            0.25                                                                            

  Structural parameters                                                                                                         

  Guinier analysis                                                                                                              

  *I*(0) (cm^−1^)                               0.04 ± 0.00                                     0.03 ± 0.00                     0.02 ± 0.00

  R~g~ (Å)                                      29.26 ± 0.25                                    28.86 ± 0.60                    27.61 ± 0.79

  *q*min (Å^−1^)                                0.01                                            0.01                            0.01

  *qRg max* (Å^−1^)                             1.3                                             1.3                             1.3

  *P(r)* analysis                                                                                                               

  *I*(0) (cm^−1^)                               0.04 ± 0.0004                                   0.029 ± 0.0003                  0.02

  R~g~ (Å)                                      30.37 ± 0.59                                    29.5 ± 0.53                     28.26 ± 0.67

  *D*~max~ (Å)                                  101.47                                          99.47                           96.99

  *q* range (Å^−1^)                             0.011--0.251                                    0.011--0.251                    0.011--0.251

  Porod volume (Å^−3^)                          71951                                           65393                           67180

  Dry volume calculated from sequence (Å^−3^)   25848                                           27271                           26622

  Shape model-fitting results                                                                                                   

  Gasbor (default paramters, 20 calculations                                                                                    

  *q* range (Å^−1^) for fitting                 0.011--0.251                                    0.011--0.251                    0.011--0.251

  Symmetry, anisotropy assumptions              *P*2, none                                      *P*2, none                      *P*2, none

  NSD (standard deviation)                      0.16 (0.004)                                    1.04 (0.55)                     

  χ^2^ range, CORMAP P values                   0.15--0.20, 0.11                                0.14--0.17, 0.47                0.14--0.15, 0.14

  Atomistic modelling                                                                                                           

  Crystal structures                            PDB entry 2H2M and 6BP6                         PDB entry 4OE9 and 6BP6         PDB entry 4OE9 and 6BP6

  q range for all modelling                     0.011--0.251                                    0.011--0.251                    0.011--0.251

  *CRYSOL* (with default parameters)                                                                                            

  No constant subtraction                                                                                                       

  χ^2^                                          0.31                                            0.72                            1.14

  Predicted Rg (Å)                              30.85                                           30.54                           31.88

  Vol (Å), Ra (Å), Dro (eÅ−3)                   53643, 1.40, 0.007                              46010, 1.400, 0.075             57201, 1.400, 0.007

  FoXS                                                                                                                          

  χ^2^, CORMAP P values                         0.52, 0.99                                      0.78, 0.99                      0.99, 0.93

  Predicted Rg (Å)                              30.82                                           29.18                           31.84

  c~1~,c~2~                                     1.03, 0.29                                      1.05, 4.0                       1.04, 1.20

  Molecular mass determination                                                                                                  

  Estimated MW from Porod volume                41387 Da                                        38094 Da                        39099 Da

  Calculated MW from MALLS                      40400 Da                                        53000 Da                        47800 Da

  Calculated MW from sequence                   21362 Da (42724 Da for dimer)                   22540 Da (45080 Da for dimer)   21819 Da (43639 Da for dimer)

  Software employed                                                                                                             

  Primary data reduction                        Australian Synchrotron SAXS/WAXS\                                               
                                                data reduction package (Scatterbrain)                                           

  Data Processing                               PRIMUS and GNOM                                                                 

  *Ab initio* modeling                          GASBOR                                                                          

  Validation and averaging                      DAMAVER                                                                         

  Computation of models                         SASREF                                                                          

  Envelope representations                      PyMOL                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------

COMMD proteins are structurally related to a unique protein from chlamydial species {#s2-7}
-----------------------------------------------------------------------------------

The COMMD proteins share no detectable sequence homology to any other proteins. However, structural comparison of the Commd9 COMM domain to the structures in the Protein Data Bank (PDB) using DALI ([@bib27]; [@bib28]) did identify low scoring (DALI Z-score \>2.5) structural matches to the PH domain of human pleckstrin as well as the phox homology (PX) domain (DALI Z-score \>3) of yeast Grd19. Interestingly, it is clear from these comparisons that the COMM domain has a similar topology to core fragments of the larger PX and PH structures ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). A closer structural match however was identified with the Pur-α (purine-rich element binding protein) repeat domain (DALI Z-score \>4.5), a whirly-like nucleic acid binding fold ([@bib24]; [@bib68]) ([Figure 4---figure supplement 4A](#fig4s4){ref-type="fig"}). Overlay of the Commd9 COMM domain with repeats of Pur-α reveals a similar fold with a RMSD of 2.5 Å over nearly 50 Cα atoms.

Intriguingly, the clearest structural matches to Commd9 are two closely related proteins from the bacterial species *Chlamydia trachomatis* (CT584) and *Chlamydia pneumoniae* (Cpn0803) ([@bib4]; [@bib54]) (DALI Z-scores \> 7.5). CT584 and Cpn0803 are orthologous proteins found only in chlamydia. They are modular proteins with an α-helical N-terminal domain and an α/β C-terminal domain, both of which are structurally analogous to the respective HN and COMM domains of Commd9 ([Figure 4---figure supplement 4B,C](#fig4s4){ref-type="fig"}). The only major difference in the C-terminal structures is the presence of two additional α-helices at the C-terminus of the bacterial proteins ([Figure 4---figure supplement 4B](#fig4s4){ref-type="fig"}). The N-terminal domains of the chlamydial proteins also have an analogous overall topology to the HN domain, except that the bacterial proteins lack α1 and α5 ([Figure 4---figure supplement 4C](#fig4s4){ref-type="fig"}). Like the COMMD molecules the chlamydial proteins possess a core dimeric structure formed by the C-terminal domains, with an overall architecture that is very similar to that of Commd9 determined by SAXS ([Figure 4---figure supplement 4D](#fig4s4){ref-type="fig"}). In addition both chlamydial proteins appear to form hexameric assemblies via trimerisation of the core dimer structure ([Figure 4---figure supplement 4E](#fig4s4){ref-type="fig"}) (discussed further below).

COMMD proteins bind promiscuously to each other {#s2-8}
-----------------------------------------------

There are now a number of high-throughput proteomics studies that point to the existence of a large multi-subunit assembly containing all of the COMMD family proteins ([@bib38]; [@bib66]; [@bib41]; [@bib13]; [@bib25]; [@bib29]). This is also well supported by several more targeted studies demonstrating that COMMD proteins associate with each other in both endogenous and over-expression conditions ([@bib66]; [@bib41]). In the majority of cases these interactions were found using co-immunoprecipitation strategies, although it has also been shown that heterodimeric complexes are formed upon bacterial co-expression of Commd1-Commd6, Commd1-Commd5 and Commd9-Commd5 ([@bib66]). To study these pairwise interactions systematically we initially attempted a GST pull down assay with purified His-tagged Commd1 and all of the GST-tagged COMMD members. However, we did not observe any significant interactions using this approach (not shown). Next, we assessed whether co-translation would lead to heterodimeric interactions. GST-baits (all COMMDs) were co-expressed in *E. coli* with selected His-tagged preys (Commd1, 7, 9 and 10) followed by affinity purification using glutathione sepharose beads ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Western blotting was used to confirm interactions unambiguously as GST and His-tagged COMMD proteins are similar molecular weights. GST-Commd8 was not included in these experiments due to the tendency of this protein to degrade. This assay reveals that all of the COMMD proteins are able to co-assemble with each other in a highly promiscuous manner, while the lack of binding using separately purified proteins suggests that no exchange occurs between pre-formed homodimeric proteins. In general there is little specificity seen in the heteromeric complexes formed, although Commd10 binds most strongly to Commd2 and Commd5 and only weakly with Commd9, while Commd9 binds weakly to Commd6.

![COMMD proteins form an array of homo and heterodimers via the C-terminal COMM domain.\
(**A**) A representative Coomassie image showing the relative expression of the GST fusion COMMD proteins (top). Blots probed with anti-His6 antibody demonstrating the direct pair-wise interactions of the COMMD protein family (bottom). A schematic representation of COMMD-COMMD interaction as demonstrated by the pull-downs. (**B, C, D**) Representative Coomassie images showing the reconstitution of full length Commd5-Commd10 complex, full length Commd5-Comm domain of Commd10 complex and complex of COMM domains of Commd5 and Commd10 respectively. (**E, F**) MALLS analyses of full length Commd5-Commd10 complex and Commd5-COMM domain of Commd10 complex showing the complexes potentially form heterotetramers based on the calculated molecular weight of the complexes.](elife-35898-fig5){#fig5}

Previous reports have shown that the COMM domain alone may be sufficient to allow interactions between COMMD proteins ([@bib10]). To test this we next performed our co-expression GST-pull down assays with His-tagged COMM domains of Commd1 and Commd9 and the HN domain of Commd1 as prey. While no interaction was observed between any COMMD proteins and the N-terminal domain of Commd1, strong interactions were seen for C-terminal COMM domains of Commd1 and Commd9 mirroring the full-length proteins ([Figure 5A](#fig5){ref-type="fig"}). Overall, our data indicates that COMMD proteins form promiscuous homo- and heterodimeric complexes through their C-terminal COMM domains. The fact that COMMD-COMMD interactions could only be reconstituted after co-translation suggest that these complexes most likely involve the formation of dimeric structures analogous to that seen in the Commd9 COMM domain crystal structure.

Reconstitution of stable heteromeric COMMD complexes {#s2-9}
----------------------------------------------------

Our GST pulldown experiment demonstrates that Commd10 preferentially binds to Commd2 and Commd5. To assess the stoichiometry of heteromeric Commd complexes, we co-expressed GST-Commd5 with Commd10-His and purified the complex by sequential affinity purification using glutathione sepharose and TALON beads. The eluted complex was subjected to size exclusion chromatography (SEC) to obtain a 1:1 stoichiometric complex. The SEC fractions under the peak clearly show reconstitution of a 1:1 Commd5-Commd10 complex ([Figure 5B](#fig5){ref-type="fig"}).

Since the COMM domain singularly mediates the formation of homo- and heteromeric complexes of COMMD proteins, we also attempted to make the complex using the full-length Commd5 and COMM domain of Commd10 and COMM domains of Commd5 and Commd10 respectively. Indeed,highly pure and stoichiometric species were isolated confirming the role of the COMM domain in COMMD complexes ([Figure 5C,D](#fig5){ref-type="fig"}). Several Commd proteins form COMM domain dependent homodimers and this prompted us to investigate the biophysical properties of Commd5-Commd10 complexes. SEC-MALLS analysis of Commd5-Commd10 reveals that the complex is highly monodisperse in solution. Although the combined theoretical molecular weight of these proteins is 47.5 kDa, the experimental mass was calculated to be 85 kDa, which suggests the existence of a Commd5-Commd10 heterotetramer ([Figure 5E,F](#fig5){ref-type="fig"}). Along the same lines, the Commd5-Commd10 COMM domain complex appears to also form a heterotetrameric assembly ([Figure 5E,F](#fig5){ref-type="fig"}). Altogether, these data raises two possibilities. First, COMM domains of Commd5 and Commd10 form homodimers and assemble together as a tetramer. Second, the Comm domain of Commd5 and Commd10 when expressed together form heterodimers ultimately forming the larger heterotetramer. In both of these scenarios, COMMD proteins are seemingly interacting with each other through a second binding interface on the COMM domain that is potentially distinct from the dimerization interface.

The COMM domains bind the calponin homology domains of CCDC22 and CCDC93 {#s2-10}
------------------------------------------------------------------------

Central to the endosomal trafficking function of COMMD proteins is their assembly into the CCC complex ([@bib38]; [@bib66]). CCDC22 and CCDC93 are large proteins predicted to contain N-terminal divergent calponin homology domains (NN-CH) and C-terminal coiled-coils ([@bib50]), and are critical components of the CCC complex ([@bib47]; [@bib5]; [@bib66]). A Commd1 knock out causes loss of CCDC22/CCDC93 ([@bib47]; [@bib5]). Therefore, we set out to examine whether CCDC22/CCDC93 directly interact with COMMDs, and their mode of association. Using the co-translation pull down assay, we found that Commd1, 7 and 10 bind to both CCDC22 and CCDC93 directly ([Figure 6A](#fig6){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Commd9 in contrast appears to recognize CCDC93 specifically. We next performed domain-truncations and conducted the binding assay with isolated calponin homology-like domains (NN-CH) and C-terminal coiled coil regions of CCDC22 and CCDC93. Interestingly, CCDC22 and CCDC93 bind to COMMDs chiefly through the NN-CH domain. Consistent with the previous literature ([@bib47]; [@bib52]), we also observed relatively weaker interaction bands for the C-terminal coiled coil domain of CCDC22 and CCDC93. Our data also shows that similar to COMMD-COMMD interaction, COMMD-CCDC22/CCDC93 binding occurs through the COMM domain.

![COMMD proteins bind directly to the N-terminal NN-CH domains of CCDC22 and CCDC93 via the COMM domain.\
(**A**) A representative coomassie gel of GST fusion protein expression in a co-expression set-up (Top). Anti-His6 blots of the GST pull down demonstrating direct interactions between the COMMD family proteins and the Coiled-coil domain proteins 22 and 93 (Bottom). (**B**) GST pull down demonstrating the binding capacity of the N-terminal domain of CCDC22 and 93 to Commd1 and Commd9 as well as their respective COMM domains. (**C** and **D**) Binding of the Commd1 COMM domain to the N-terminal domains of CCDC22 (**C**) and CCDC93 (**D**) measured at varying concentrations using the BLiTz system. Binding kinetics we calculated using Sigma Plot (Systat Software Inc.).](elife-35898-fig6){#fig6}

In contrast to interactions between COMMD family members, which require co-expression for assembly, we find that CCDC22 and CCDC93 interaction with pre-formed COMMD dimers occurs spontaneously in vitro ([Figure 6B](#fig6){ref-type="fig"}). GST-pull down experiments conducted by mixing the purified GST-NN-CH domain of CCDC22 and CCDC93 with full length Commd1 and Commd9 as well as the COMM domains showed a similar binding pattern to what was observed after co-expression ([Figure 6A,B](#fig6){ref-type="fig"}). Specifically, Commd1 and Commd9 bind more strongly to the N-terminal NN-CH domain of CCDC93 in comparison to CCDC22. Moreover, this assay also suggests that Commd1 has stronger affinity than Commd9 for CCDC proteins. The interaction of the CCDC22 and CCDC93 NN-CH domains with the COMM domain of Commd1 was recapitulated and quantified using biolayer interferometry (BLiTz). A dose-dependent increase in the binding of the COMM domain of Commd1 with NN-CH of CCDC22 and CCDC93 was observed, and the affinity (*K*~d~) was calculated to be 10.3 and 14.6 µM respectively ([Figure 6C,D](#fig6){ref-type="fig"}).

Commd proteins bind to CCDC22 and CCDC93 via a conserved site {#s2-11}
-------------------------------------------------------------

To identify the molecular determinants that govern the interaction between the COMM domain of COMMDs and NN-CH domain of CCDC22 and CCD93, we used cross-linking mass spectrometry (MS) in combination with pull down experiments. Non-deuterated BS3 cross-linker was used to crosslink full-length Commd9 with the NN-CH domain of CCDC93. Due to the availability of HN and COMM domain structures, Commd9 was chosen for these experiments. The NN-CH domain of CCDC22 could not be used as it does not contain any lysine residues. Upon crosslinking, three major bands (labeled as 1, 2 and 3) in the Commd9 and NN-CH domain of CCDC93 mixture were observed, which were excised for MS analysis ([Figure 7A](#fig7){ref-type="fig"}). Lysozyme was used as a negative control, and a similar presence of bands 1 and 3 suggest they are likely to be cross-linked dimers and tetramers of Commd9 alone ([Figure 7A](#fig7){ref-type="fig"}). This observation was further supported by inspection the MS spectra and xQuest database ([Table 3](#table3){ref-type="table"}). Analyses of MS data from band 2 revealed 5 unique cross-links, and 3 of these pairs connected Commd9 and NN-CH domain of CCDC93 ([Figure 7B](#fig7){ref-type="fig"} and [Table 3](#table3){ref-type="table"}). Mapping of these pairs onto the crystal structures of Commd9 showed that all three lysines (K100, K133 and K152) were located on the surface accessible to the solvent ([Figure 7C,D](#fig7){ref-type="fig"}). Notably, K133 and K152 are located on contiguous surfaces of the β-sheets of the COMM domains ([Figure 7D](#fig7){ref-type="fig"}), suggesting a likely binding surface for the CCDC93 NN-CH domain. This surface also includes the side-chains of the conserved residues ^128^WRVD^131^, with Trp128 in particular being strictly conserved across the entire Commd family ([Figure 2B](#fig2){ref-type="fig"}).

![COMMD proteins bind to NN-CH domain of CCDC93 via the conserved WRVD motif in the COMM domain.\
(**A**) Cross-linking of Commd9, NN-CH domain of CCDC93 and the mixture of two with BS3 for 30 min at room temperature. Three distinguishable SDS-PAGE gel bands were excised in the complex mixture sample (indicated by the number 1, 2 and 3) for MS analysis. In parallel, a cross-linking reaction between Commd9 and lysozyme was performed under the same condition. (**B**) Cross-link map for Commd9 in complex with the NN-CH domain of CCDC93. Intermolecular and intramolecular cross-linked peptides are labelled as black and brown dot lines respectively. (**C** and **D**) Ribbon representation of the Commd9 HN (**C**) and (**D**) COMM domain structures with mapped intramolecular and intermolecular cross-linked lysine residues (in spheres). In the Commd9 COMM domain, K133 and K152 are part of a contiguous surface that includes the side-chains of the conserved residues ^128^WRVD^131^ (indicated with sticks).](elife-35898-fig7){#fig7}

10.7554/eLife.35898.019

###### Identified cross-linked peptides of Commd9 and NN-CH domain of CCDC93.

  Predicted mass (Da)   Observed mass (Da)   Error (ppm)       xQuest score                                                   
  --------------------- -------------------- ----------------- -------------- ----------------------------------------------- --------------------
  Sample 1:                                  Commd9 - Commd9                                                                  
  2751.419              2751.407             2.3               21.10          VDIK(133)TSSDSISR-VDIK(133)TSSDSISR             
  2305.209              2305.206             3.0               20.35          ASSK(21)DVVR-VDIK(133)TSSDSISR                  
  4316.319              4316.306             3.2               18.78          DLSSAEAILALFPENFHQNLK(95)NLLTK(100)IILEHVSTWR   
  3266.789              3266.782             1.8               18.67          NLLTK(100)IILEHVSTWR-VDIK(133)TSSDSISR          
  2820.589              2820.579             2.4               17.28          ASSK(21)DVVR-NLLTK(100)IILEHVSTWR               
  3648.889              3648.881             1.0               15.22          LVDLDWRVDIK()TSSDSISR-VDIK(133)TSSDSISR         
  3202.679              3202.677             2.0               14.22          ASSK(21)DVVR-LVDLDWRVDIK(133)TSSDSISR           
  2571.299              2571.288             4.1               12.78          IQEDPSLCGDK(163)PSISAVTVELSK(175)               
  1859.009              1859.006             2.7               12.40          ASSK(21)DVVR-ASSK(21)DVVR                       
  Sample 2:             Commd9 - CCDC93                                                                                       
  2998.479              2998.476             1.5               16.86          VDIK(133)TSSDSISR                               AIETK(131)EEMGDYIR
  3513.859              3513.842             1.4               14.74          NLLTK(100)IILEHVSTWR                            AIETK(131)EEMGDYIR
  4772.479              4772.501             5.1               7.11           MAVPTCLLQMK(152)IQEDPSLCGDKPSISAVTVELSK         IK(45)GLSPFDK
                                                                              Commd9 - Commd9                                 
  2820.589              2820.583             1.1               18.60          ASSK(21)DVVR-NLLTK(100)IILEHVSTWR               
                                                                              CCDC93 - CCDC93                                 
  3569.679              3569.675             0.3               14.92          AIETK(131)EEMGDYIR-SYSVSQFQK(148)TYSLPED        
  Sample 3:             Commd9 - Commd9                                                                                       
  2820.589              2820.599             4.6               20.02          ASSK(21)DVVR-NLLTK(100)IILEHVSTWR               
  2305.209              2305.226             5.8               19.51          ASSK(21)DVVR-VDIK(133)TSSDSISR                  

To minimize the possibility that the cross-linked peptides captured were non-specific interactions caused by BS3, we also performed a cross-linking reaction using the unrelated VPS26 -- VPS29 -- VPS35 retromer complex from zebrafish (hereafter designated as zfRetromer) as a positive control. Inspection of the xQuest database and the MS spectra reveal a total of 18 cross-linked peptides ([Table 4](#table4){ref-type="table"}). VPS26 and VPS29 mainly cross-linked to two opposite regions of VPS35, which is in good agreement with the known crystal structures of Retromer ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). This implies that the cross-links we observe between Commd9 and CCDC93 are specific.

10.7554/eLife.35898.020

###### Identified cross-linked peptides of zfRetromer.

  Predicted mass (Da)                    Observed mass (Da)   Error (ppm)   xQuest score                                                                           
  -------------------------------------- -------------------- ------------- -------------- ------------------------------------------- --------------------------- ------------------------
  Intermolecular cross-linked peptides   zfVPS26              zfVPS29       zfVPS35                                                                                
  2929.569                               2929.550             8.0           13.20          APEK(301)MR                                                             K(90)VADLYELVQYAGNIIPR
  1844.019                               1844.040             9.4           10.12          SKYHLK(188)                                                             NK(38)LMDALK
  1342.809                               1342.805             4.9           9.99           MRK(304)R                                                               K(127)DILK
  1756.069                               1756.070             2.8           9.83                                                       FK(23)KLLVPGK               WEKK(556)
  3809.959                               3809.982             7.1           8.01                                                       GDFDENLNYPEQK(73)VVTVGQFK   TQCALAASK(659)LLK
  Intramolecular cross-linked peptides   zfVPS26 -- zfVPS26                                                                                                        
  1441.829                               1441.819             3.3           28.12          VNINVK(57)QTSK(61)R                                                     
  1630.869                               1630.863             4.6           26.54          TAELK(30)TEEGK(35)LEK                                                   
  1247.689                               1247.679             2.1           26.15          DVNK(266)K(267)FSVR                                                     
  2571.239                               2571.229             4.3           22.06          TEEGK(35)LEK(38)HYLFYDGESVSGK                                           
  3241.639                               3241.662             7.0           20.14          K(25)TAELKTEEGK(35)LEKHYLFYDGESVSGK                                     
  3626.859                               3626.875             5.8           19.78          K(214)EMTGIGPSTTTETETVAK-YFK(288)QQEIVLWR                               
  844.489                                844.487              4.4           18.66          K(25)TAELK(30)                                                          
  1014.549                               1014.544             1.4           12.32          K(297)APEK(301)MR                                                       
  Intramolecular cross-linked peptides   zfVPS29 - zfVPS29                                                                                                         
  1184.749                               1184.736             5.9           18.59          FK(23)KLLVPGK(30)                                                       
  Intramolecular cross-linked peptides   zfVPS35 -- zfVPS35                                                                                                        
  1607.729                               1607.726             3.3           22.38          ENSSSDDK(552)WEKK(556)                                                  
  844.469                                844.449              6.9           19.26          EK(208)REK(211)                                                         
  2245.219                               2245.215             5.1           18.55          LLDEAVQAVK(24)VQSFQMK(31)R                                              
  1255.699                               1255.688             2.5           17.69          LLK(662)K(663)PDQCR                                                     

COMMD proteins associate non-specifically with negatively charged phospholipids {#s2-12}
-------------------------------------------------------------------------------

COMMD proteins are peripheral membrane proteins commonly associated with endosomal compartments ([@bib47]; [@bib5]; [@bib66]; [@bib41]; [@bib9]; [@bib14]). To examine if COMMD family proteins possess membrane-binding properties we performed qualitative liposome-pelleting assays with purified COMMD proteins ([Figure 8A](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). The assay shows that Commd1 associates relatively non-specifically with various negatively charged membranes, including PC/PE liposomes doped with different phosphoinositides, generic Folch lipids from brain extracts, and liposomes containing 30% phosphatidylinositolserine (PS). We observed a similar binding characteristic for Commd7, but Commd10 showed a relatively strong interaction with Folch liposomes as well as di- and tri- phosphorylated phosphoinositide species.

![COMMD proteins bind membrane phospholipids but this is not required for endosomal recruitment.\
(**A**) Commd1, Commd1 (R133Q, H134A, K167A), Commd7, Commd9 and Commd10 were incubated with POPC (100%), POPC/POPE (90:10, molar ratio), POPC/POPE/POPS (60:10:30, molar ratio) and POPC/POPE/PIP (80:10:10, molar ratio) liposomes doped with different phosphoinositides to perform liposome pelleting assay by ultracentrifugation and subsequent protein content analysis of the supernatant (S) and pellet (P) fractions. (**B**) (Left) Homology model of Commd1 COMM domain shown as a transparent electrostatic surface overlaid with the ribbon representation, highlighting the residues crucial for forming the positively charged lipid-binding pocket. Inset shows the close up of the lipid-binding pocket. (Right) The electrostatic surface representation of Commd9 COMM domain, highlighting the absence of basic patch. (**C**) Sequence alignment of Commd1 and Commd9 COMM domains. Red asterisks mark the positively charged amino acids constituting the basic patch on Commd1, which are absent in Commd9. (**D--H**) Binding of liposomes containing various phosphoinositides to Commd1 measured at different concentrations and Commd1 (R133Q, H134A, K167A) using the BLiTz system. Binding kinetics was calculated using sigma-plot (Systat Software Inc.). (**I**) Lentiviral constructs of GFP-tagged Commd1 and Commd1 (R133Q, H134A, K167A) were transfected into HeLa cells and colocalisation with the Fam21 WASH subunit imaged by confocal immunofluorescence microscopy. The mutant Commd1 is still recruited to endosomes, presumably due to incorporation into heteromeric COMMD complexes and the CCC/Retreiver subunits.](elife-35898-fig8){#fig8}

In contrast to the other family members, Commd9 appears to associate weakly if at all with the membranes tested ([Figure 8A](#fig8){ref-type="fig"}). A comparative analysis of the electrostatic surface of the COMM domain of Commd9 and a homology model of the COMM domain of Commd1 (constructed using the COMM domain of Commd9 as the template) shows that the Commd1 COMM domain exhibits a basic patch on its surface composed of solvent-exposed positively charged residues that are absent in Commd9 ([Figure 8B,C](#fig8){ref-type="fig"}). To test if this basic surface on Commd1 is involved in membrane recruitment, we made a triple mutant in the putative lipid-binding site (R133Q, H134A and K167A). In liposome-pelleting assays this mutant shows a drastic reduction in membrane interaction ([Figure 8A](#fig8){ref-type="fig"}).

Using BLiTz we next quantified the interactions of Commd1 and Commd9 with different phosphoinositide-containing membranes. While Commd1 possesses a higher level of binding response for phosphoinositides PI(3)*P* and PI(4,5)*P*~2~ compared to Folch and PS containing membranes, Commd9 showed little association with any of the lipids tested, in line with the liposome-pelleting assay ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). We performed a concentration-dependent binding series with a selection of liposomes and Commd1 to calculate the dissociation constants of these interactions. Commd1 binds to a variety of liposomes with similar affinities in the range of 1--10 µM, which is in agreement with the qualitative results from pelleting assays ([Figure 8D,E,F,G and H](#fig8){ref-type="fig"}). Confirming the importance of the basic patch on the Commd1 COMM domain, no interaction was observed with the Commd1 triple mutant. Altogether, the COMM domain of COMMD proteins appears to be a central hub for both protein-protein and protein-membrane interactions.

We next assessed the importance of the Commd1 membrane-binding surface for its cellular localization. GFP-tagged Commd1 wild type and mutant were expressed in HeLa cells following lentiviral transduction ([Figure 8I](#fig8){ref-type="fig"}). As seen previously, Commd1 is localized to endosomal puncta, and colocalises with the WASH complex subunit Fam21. Surprisingly however, the mutant Commd1 is also colocalised with Fam21 on endosomes, despite being defective for membrane binding in vitro. We propose therefore that this site on Commd1 may instead be important for non-specific membrane interactions and perhaps for the orientation of the CCC complex on endosomes, but in the context of the assembled complex with other COMMD proteins it is not required for specific recruitment to PtdIns3*P*-enriched endosomal compartments.

Discussion {#s3}
==========

The COMMD proteins were recently identified as conserved and central components of the CCC complex ([@bib38]; [@bib66]; [@bib41]), a large endosome-associated assembly that regulates cell surface recycling of various transmembrane receptors ([@bib41]; [@bib47]; [@bib5]; [@bib66]). Despite the high degree of conservation of the COMMD proteins, and the CCC complex more generally, little is known about the structures or the stoichiometries of the component subunits, or how these proteins assemble together to control membrane recruitment and protein trafficking. In this study we provide the first insights into the architecture of the COMMD proteins, and the mechanisms that underpin the previously reported interactions between the various family members. COMMD proteins form obligatory dimers, and interact with each other in promiscuous homo- and heterodimeric arrangements via the C-terminal COMM domain. Furthermore this small domain is essential for pleiotropic interactions with both the CCC proteins CCDC93 and CCDC22, and with negatively charged phospholipid membranes. The solution structures of Commd1, Commd7 and Commd9 reveal a modular architecture with the α-helical N-terminal HN domains arranged as flexible appendages to the C-terminal COMM domain dimers. Previous studies had described the N-terminal region as a variable domain that could provide functional diversity to the COMMD proteins, due to the low level of sequence homology in this region across the family. Our biophysical, structural and bioinformatics analyses however show that the HN domain is a structurally conserved feature shared by all COMMD family members.

The architecture of the COMMD proteins revealed here bears a remarkable resemblance to the orthologous CT584 and Cpn0803, *Chlamydia*-specific proteins from *C. trachomatis* and *C. pneumonia* respectively. The function of these proteins is unknown, although there is evidence that Cpn0803 can interact with phospholipids as well as components of the Type III secretion system responsible for injection of bacterial effectors into the host cytoplasm ([@bib54]). What does the homology of COMMD proteins to these chlamydial proteins imply? Chlamydial species are intracellular pathogens that reside inside a membrane vacuole called the inclusion. During their life cycle they secrete many effectors that can hijack the intracellular trafficking and signalling machinery of the host cell to promote survival ([@bib15]; [@bib42]; [@bib18]; [@bib48]). We speculate therefore that the CT584/Cpn0803 proteins may be secreted effectors with a potential to mimic or modify COMMD protein functions, although this remains to be confirmed. The evolutionary relationship of the COMMD proteins to the chlamydial homologues is also an interesting question. Several chlamydial proteins are believed to have evolved through horizontal gene transfer from eukaryotic hosts, such as SWIB domain-containing proteins and Swi/Snf2 helicases ([@bib7]; [@bib53]), and it is possible that the CT584/Cpn0803 genes have been acquired in a similar fashion. Both CT584 and Cpn0803 form hexameric structures composed of a trimer of dimers, with the N-terminal domains providing the primary interface for trimer formation ([@bib4]; [@bib54]) ([Figure 4---figure supplement 4E](#fig4s4){ref-type="fig"}). While full-length recombinant Commd1, Commd7 and Commd9 proteins analysed here form homodimers, it is tempting to speculate that the N-terminal domains of COMMD proteins will contribute to formation of higher-order heteromeric assemblies that are present in the 600 kDa CCC complexes isolated from cultured cells ([@bib66]), the stoichiometries and structures of which remain to be determined.

Although the COMMD proteins play a central role in endosomal membrane trafficking as components of the CCC complex, they have also been implicated in a number of other cellular processes. The gene encoding Commd1 (originally called Murr1) was originally identified in dogs with copper toxicosis, which has been mechanistically linked to interactions with the Wilson disease ATPase protein ATP7B ([@bib56]). Most prominently, Commd1 has been shown to be a potent inhibitor of the transcription factor NF-κB, a master regulator of inflammation, and other COMMD proteins also display similar activities ([@bib35]; [@bib12]; [@bib21]; [@bib6]). Commd1 acts downstream of the inhibitory IκB kinase ([@bib21]), and is believed to associate with NF-κB subunits at chromosomal loci and promote NF-κB ubiquitination by Cullin family ubiquitin ligases for degradation ([@bib36]; [@bib39]). A similar function has been proposed for Commd1 regulation of the HIF-1α transcription factor ([@bib61], [@bib60], [@bib59]). The COMM domain fold is structurally related to the repeat domains found in the PUR (purine-rich element binding protein) family protein Pur-α ([@bib24]; [@bib68]). Pur-α contains three such repeat domains, the first two of which form an intramolecular 'dimer' while the third forms an intermolecular dimer ([@bib68]) that both resemble the dimeric COMM domain topology. Pur-α is a nucleic acid binding protein that plays important roles in the transcription of neuronal genes ([@bib20]; [@bib69]), and is associated with GGGGCC-containing inclusions in ALS-FTD patients ([@bib71]). The similarity of the COMM domain with Pur-α suggests the intriguing possibility that COMMD proteins could also interact with DNA and/or RNA to regulate transcription, although it should be noted that the specific DNA binding site in Pur-α ([@bib68]) is not conserved in the COMMD proteins ([Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}).

The CCC complex and associated COMMD proteins are predominantly localised to early endosomal membranes ([@bib47]; [@bib5]; [@bib66]; [@bib41]; [@bib9]; [@bib14]). The mechanism of membrane recruitment of the complex however is unknown. Most intracellular trafficking complexes rely on binding to proteins such as the Rab GTPases and membrane lipids such as phosphoinositides for their spatio-temporal recruitment to specific compartments ([@bib11]). COMMD proteins show significant but non-preferential binding to a variety of negatively charged lipids, and these interactions appear to be maintained by the COMM domain. Our data also highlights that the HN domain is dispensable for membrane association, which is in line with the work of Burkhead et al. ([@bib9]). The membrane-binding surface of Commd1 in vitro is composed of residues from both molecules of the homodimer, but interestingly this does not appear essential for endosomal localisation of Commd1 in cells. This suggests that the ability of COMMD proteins to associate with membranes is only one part of a more complicated array of interactions controlling specific endosomal membrane recruitment, likely involving different lipid binding properties of heterodimeric COMMD proteins and other CCC complex subunits. Supporting a role for other subunits and complexes in specific endosomal localisation of the CCC complex, the depletion of CCDC93 or the WASH complex subunit Fam21 both lead to a loss of Commd1 from endosomes ([@bib47]), while the depletion of CCDC22 causes a redistribution of Commd1 and Commd10 ([@bib52]).

The ability to self-assemble and form heteromeric complexes is a core property of the COMMD proteins identified in some of the very first studies ([@bib10]). Our work provides a clear structural explanation for how homo- and heterodimers are formed by the different family members, and begins to suggest mechanisms for how different domains could contribute to the formation of larger assemblies, how they associate with biological membranes, and how they become incorporated into the CCC complex through interactions with the CCDC proteins. As COMMD-containing complexes emerge as key regulators of cellular trafficking, signalling and transcription, the details of these molecular interactions and the systems that regulate them remain outstanding questions to be answered.

Materials and methods {#s4}
=====================

Antibodies and phospholipids {#s4-1}
----------------------------

The monoclonal mouse anti-His antibody was purchased from Genscript Corporation (catalog no. A00186, 1:5000). Goat anti-mouse IgG HRP was from Life Technologies (Catalog no. A16072, 1:1000). POPC (1-palmitoyl-2oleoyl-sn-glycero-3-phosphocholine) (catalog no. 850475P), POPE (1-palmitoyl-2oleoyl-sn-glycero-3-phosphoethanolamine) (catalog no. 850757P), DOPS (1,2-dioleoyl-snglycero-3-phosphoserine) (catalog no. 850150P) and biotinylated POPE (1-palmitoyl-2oleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl)) (catalog no. 870285P) were purchased from Avanti Polar Lipids. PI (1,2-dioleoyl-sn-glycero-3-phospho-(1\'-myo-inositol)) (catalog no. P-0016), PI(3)P (1,2-dioctanoyl-sn-glycero-3-(phosphoinositol-3-phosphate)) (catalog no. P-3016), PI(4)P (1,2-dioleoyl-sn-glycero-3-phospho-(1\'-myo-inositol-4\'-phosphate)) (catalog no. P-4016), PI(5)P (1,2-dioleoyl-sn-glycero-3-phospho-(1\'-myo-inositol-5\'-phosphate)) (catalog no. P-5016), PI(3,4)P~2~ (1,2-dioctanoyl-sn-glycero-3-phospho-(1\'-myo-inositol-3\',4\'-bisphosphate)) (catalog no. P-3416), PI(3,5)P2 (1,2-dioctanoyl-sn-glycero-3-phospho-(1\'-myo-inositol-3\',5\'-bisphosphate)) (catalog no. P-3516), PI(4,5)P~2~ (1,2-dioctanoyl-sn-glycero-3-phospho-(1\'-myo-inositol-4\',5\'-bisphosphate)) (catalog no. P-4516) and PI(3,4,5)P~3~ (1,2-dioctanoyl-sn-glycero-3-phospho-(1\'-myo-inositol-3\',4\',5\'-trisphosphate)) (catalog no. P-3916) lipids were obtained from Avanti Polar Lipids, Inc.

Molecular biology and cloning {#s4-2}
-----------------------------

All the constructs cloned into bacterial expression plasmids are listed in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. Briefly, DNA encoding full-length human Commd proteins and CCDC22 and, 93 was cloned into the pGEX-4T-2 plasmid for expression as N-terminal GST-tagged fusion proteins. Full length Commd1, 7 and 9 were also cloned into the pET30b(+) vector with a C-terminal His6 tag by Genscript Corporation. Commd1 HN domain (1-114), Commd1 COMM (116-190), Commd9 HN domain (1- 116), Commd9 COMM (115-198), CCDC22_N (1-139), CCDC22_C (194-627), CCDC93_N (17-155) and CCDC93_C (239-630) were artificially synthesized by Genscript Corporation and cloned into both pGEX-6P-1 and pET30b(+) plasmid as N-terminal GST tagged and C-terminal His6 tagged fusion proteins respectively. Genscript Corporation generated all the mutants used in this study. The construct used in crystallization of Commd9 HN domain (1-117) was cloned into pDEST17 with an N-terminal His6 tag.

Recombinant protein expression and purification {#s4-3}
-----------------------------------------------

The bacterial expression plasmids were transformed into *Escherichia coli* BL21-CodonPlus (DE3)-RIPL competent cells (Agilent). The bacterial cultures were grown in LB until OD~600nm~ reached 0.6. The cultures were cooled to 18˚C before inducing protein expression by adding 0.5 mM isopropylthio-β-galactoside (IPTG) and allowed to grow for 16 h ([@bib22]). The cells were harvested by centrifugation at 6000 × g for 5 min at 4˚C and the harvested cell pellet was resuspended in lysis buffer \[20 mM Tris (pH 8.0), 500 mM NaCl, 10% glycerol, 0.2% IGEPAL, 50 μg/mL benzamidine, 100 units DNaseI, and 1 mM β-mercaptoethanol\]. Cells expressing His6-fused proteins were resuspended in lysis buffer supplemented with 20 mM imidazole (pH 8.0). The cells were lysed by mechanical disruption at 30 kpsi using a Constant systems cell disrupter. The lysate was clarified by centrifugation at 50,000 × g for 30 min at 4˚C. Proteins were purified using affinity chromatography from the clarified lysate.

His-tagged proteins were purified on a nickel-NTA (Clonetech) gravity column and eluted with 500 mM imidazole in buffer containing 150 mM NaCl, 20 mM Tris (pH 8.0) and 1 mM β-mercaptoethanol. GST-tagged proteins were purified on a glutathione-Sepharose (GE healthcare) gravity column and eluted with 10 mM glutathione, 150 mM NaCl, 20 mM Tris (pH 8.0) and 1 mM β-mercaptoethanol or the GST tag was cleaved with the addition of thrombin or precision protease cleavage on to the beads with overnight incubation at room temperature. Finally, proteins were subjected to size exclusion chromatography using a superdex-200 16/60 Hiload column or superdex-75 16/60 Hiload column attached to an AKTA pure (GE Healthcare).

The Commd5-Commd10 complexes were reconstituted by co-transformation of GST-Commd5 or GST-tagged COMM domain of Commd5 with Commd10-His or His-tagged COMM domain of Commd10 into *Escherichia coli* BL21 (DE3) competent cells (Agilent). The cells were cultured, harvested and lysed as described above. The complexes were first purified using glutathione sepharose beads and the GST tag was cleaved using prescission protease. The eluted fractions were then mixed with equilibrated TALON beads to obtain a 1:1 stoichiometric complex. The complexes were eluted by supplementation of 200 mM Imidazole (pH 8.0) in the wash buffer. The eluted proteins were subjected to size exclusion chromatography using a superdex-200 16/60 Hiload column.

For crystallization, SAXS, and MALLS experiments, proteins were buffer exchanged into 10 mM Tris (pH 8.0), 100 mM NaCl and 2 mM DTT using SEC. For the structure determination of Commd9 COMM domain, the protein was labeled with selenomethionine using the method described by Van Duyne et al ([@bib63]). zfVPS26, zfVSP29 and zfVPS35 were expressed separately in *E. coli* BL21 (DE3) cells grown in LB at 37°C, and protein expression was induced at an OD600 of 0.7--0.8 by the addition of 1 mM IPTG. Cells were harvested after 18 hr of growth at 18°C. Cell pellets of overexpressed zfVPS26, zfVSP29 and zfVPS35 were mixed and purified using standard metal affinity, glutathione affinity and size-exclusion chromatography techniques to obtain the purified retromer complex. The size-exclusion buffer contains 50 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM DTT.

Multi-angle laser light scattering {#s4-4}
----------------------------------

The molecular mass of the COMMD proteins was determined by size exclusion chromatography on an AKTA pure (GE Healthcare) connected to a multi angle laser light scattering and, differential refractive index (RI) detector. The protein samples were gel-filtered in a buffer containing 25 mM Tris (pH 8.0), 300 mM NaCl and 2 mM DTT that had been filtered (0.22 μm) and degassed. Measurements of full-length COMMD proteins were made using a superdex-200 increase 5/150 column (GE Healthcare) at a flow rate of 0.25 ml/min with in-line UV, MALLS, and RI detectros (Dawn Heleos II and Optilab reX, respectively, Wyatt Technology Corp) for M~W~ characterization. Measurements of the COMMD COMM and HN domains were made using a superdex-75 5/150 column (GE Healthcare) at a flow rate of 0.25 ml/min. UV, MALLS and RI data were collected and analysed using the ASTRA^TM^ software (Wyatt Technology) ([@bib19]) to compute the molecular mass.

Crystallisation, data collection and structure determination {#s4-5}
------------------------------------------------------------

The Commd9 COMM domain was buffer-exchanged into 10 mM Tris (pH 8.0), 100 mM NaCl, 2 mM DTT, and concentrated to 8 mg/ml for crystallisation at 20˚C. The protein was supplemented with 10 mM DTT before setting up hanging-drop crystallization screens using a mosquito liquid handling robot (TTP LabTech). Commd9 COMM was crystallised in 0.1 M HEPES (pH 7.0), 6% Jeffamine M-600.

In the case of the Commd9 HN domain, protein was buffer exchanged into 50 mM HEPES (pH 8.0), 200 mM NaCl, 1 mM tris (2-carboxyethyl) phosphine (TCEP) and initial crystallisation screens were set up at 12 mg/ml at 18 ˚C. Crystals of the HN domain were obtained in 0.2 M citric acid (pH 4.9), 28% MME-PEG5000 in a hanging drop setup respectively. Data were collected at the Australian Synchrotron MX1 and MX2 Beamlines. iMOSFLM ([@bib8]) was used to integrate the data, and AIMLESS ([@bib17]) was used for data scaling in the CCP4 suite ([@bib70]). The Commd9 COMM domain structure was solved using single anamolous dispersion (SAD), and the phases were calculated using the peak wavelength data of selenium with AUTOSOL using the PHENIX suite ([@bib1]; [@bib57]). The solution from AUTOSOL was built using autobuild ([@bib58]) and the resulting model was rebuilt with COOT ([@bib16]) followed by repeated refinement runs and model building with PHENIX ([@bib1]) and COOT ([@bib16]). The Commd9 HN domain structure was determined using multiwavelength anamolous dispersion (MAD) and the phases were obtained using the program SOLVE. Model building and refinement was done using COOT and PHENIX refine.

Small angle X-ray scattering {#s4-6}
----------------------------

In line SEC-SAXS measurements on homogeneous protein samples (assessed using MALLS) were performed at the SAXS/WAXS beamline at the Australian Synchrotron using a superdex-200 increase 5/150 column (GE Healthcare), and Pilatus 1M detector (Dectris). The scattering data were measured in a q range of 0.011 to 0.4 Å at 12 keV using a 1.6 m camera length. Samples were loaded on to the size exclusion column that was equilibrated with 10 mM Tris (pH 8.0), 100 mM NaCl, 2 mM DTT and 5% Glycerol. Data reduction was performed using the ScatterBrain program (written and provided by the Australian Synchrotron; available at <http://www.synchrotron.org.au>). The buffer frames were averaged after assessing the statistical equivalence using CorMap p values with a significance threshold (α) of 0.01. The averaged buffer scattering was subtracted from statistically similar data from Commd proteins elution peak. *R~g~* was evaluated using the Guinier approximation and was found to be consistent under the elution peak. Primary data processing was performed in Primus using the ATSAS suite (version 2.6) ([@bib45]). Pair distance distribution *P(r)* of Commd proteins was determined using GNOM. C~2~ symmetry was assumed in generating low-resolution three-dimensional *Ab initio* envelopes using the program GASBOR ([@bib30]). DAMAVER ([@bib64]) was used to average the 20 independent models generated by GASBOR. Rigid body modeling was performed using SASREF ([@bib46]) and the partial scattering amplitudes were calculated with CRYSOL ([@bib55]). The *ab initio* models were superimposed on to the rigid body modeled structures using SUPCOMB ([@bib30]).

Co-expression GST pull-downs {#s4-7}
----------------------------

BL21-CodonPlus (DE3)-RIPL competent cells were co-transformed with either His6-tagged Commd1, Commd1 COMM domain, Commd1 HN domain, Commd9, Commd9 COMM domain or Commd10 with each of the GST-tagged proteins of interest (Commd1-10, CCDC22, CCDC22_N (1-139), CCDC22_C (194-627), CCDC93_N (17-155), CCDC93_C (239-630) and empty pGEX4T-2 vector (expressing GST). Transformants were selected via overnight growth using triple antibiotic agar plates. A single colony was picked to initiate the culture and proteins were co-expressed using the standard protein expression protocol as described above. Proteins were purified by affinity chromatography using glutathione sepharose beads (GE healthcare) and SDS-PAGE was run to visualize GST-tagged bait proteins. Binding of His-tagged proteins (prey) to GST-tagged (bait) was observed by Western blotting using mouse anti-His antibody (Genscript). Genscript generated all the mutants used in this study.

GST pull downs {#s4-8}
--------------

1 nmol GST-tagged CCDC22_N (1-139) and CCDC93_N (17-155) were mixed with 1 nmol of His-tagged Commd1 and Commd9, and COMM domains of Commd1 and Commd9 and Commd1 HN domain, for 1 hr at 4˚C. Protein mixture was then centrifuged at high speed to remove any precipitated proteins. The supernatant was then added to pre-equilibrated (20 mM Tris (pH 8.0), 300 mM NaCl, 1 mM DTT) glutathione sepharose and allowed to mix for a further 30 min at 4˚C. Beads were washed five times in the above buffer supplemented with 0.5% triton X100 (Sigma Aldrich). Bound proteins were analysed by Western blots using mouse anti-His antibody (Genscript).

Chemical Cross-linking coupled with mass spectrometry {#s4-9}
-----------------------------------------------------

For cross-linking, the purified full-length Commd9 and NN-CH domain of CCDC93 mixture at 50 μM in 50 mM Hepes (pH 7.5), 150 mM NaCl were incubated with 100 molar excess of BS3-d0 cross-linker (Sigma-Aldrich) for 30 min at room temperature. The reaction was quenched by addition of 100 mM Tris-HCl (pH 8.5), and the cross-linked products were analysed by SDS-PAGE and subjected to MS analysis. A negative control cross-linking reaction was performed between the full-length Commd9 and lysozyme using the same condition described above. For the positive control cross-linking reaction, the purified retromer complex at 15 μM was reacted with 100 molar excess of BS3-d0 cross-linker. BS3-d0 was purchased from Sigma Aldrich (catalog no. S5799). The gel band that corresponds to the molecular weight of monomeric retromer complex was subjected to MS analysis. The bands from the SDS-PAGE gels were excised and reduced with dithioerythritol followed by alkylation with iodoacetamide. Alkylated samples were digested with trypsin (Promega) in 50 mM ammonium bicarbonate pH 8.0 overnight using an enzyme-to-substrate ratio of 1:100 (w/w) at 37°C. The digested samples were extracted using extraction buffer containing 5% formic acid and 50% acetonitrile followed by sonication for 1 min. The supernatant was then dried down in a vacuum centrifuge and redissolved in 0.1% formic acid prior to analyse by LC-MS/MS. The extracted peptides were analysed by uHPLC-MS/MS on an Eksigent, Ekspert nano LC400 uHPLC (SCIEX, Canada) coupled to a Triple Tof 6600 mass spectrometer (SCIEX, Canada) equipped with a duo microelectrospray ion source. In brief, samples were injected onto a 300 µm x 150 mm ChromXP C18 CL 3 µm column (SCIEX, Canada) at 5 µl/min. The bound peptides were eluted with a gradient using solvent containing 0.1% formic acid in acetonitrile. 250 ms full scan TOF-MS data was acquired followed by up to 30 50 ms full scan product ion data in an Information Dependant Acquisition, IDA, mode. TOFMS data was acquired over the mass range 350--2000 and for product ion ms/ms 100--1600. Ions observed in the TOF-MS scan exceeding a threshold of 100 counts and a charge state of +2 to +5 were set to trigger the acquisition of product ion, ms/ms spectra of the resultant 30 most intense ions. Acquisition of all MS/MS samples was performed using Analyst TF 1.7 software (SCIEX, Canada). Inspection of the raw MS data was done using ProteinPilot software (SCIEX, Canada). The assignment of cross-linked peptides was made based on xQuest database search engine ([@bib49]). Trypsin was set as the enzyme used for digestion during sample preparation with an MS1 tolerance of 10 ppm and MS2 tolerance of 0.2 m/z.

Liposome preparation {#s4-10}
--------------------

All the phosphoinositides were protonated prior to usage. In brief, powdered lipids were resuspended in chloroform (CHCl~3~) and dried under argon. Dried lipids were then left in a desiccator for 1 hr to remove any remaining moisture. Dried lipids were resuspended in CHCl~3~:Methanol (MeOH):1N hydrochloric acid in a 2:1:0.01 molar ratio, lipids were dried once again and allowed to desiccate. Lipids were then resuspended in CHCl~3~:MeOH in a 3:1 ratio dried once again under argon. Finally, dried lipids were resuspended in CHCl~3~ and stored at −20°C.

Lipid stock solutions were mixed to the desired molar ratios and dried under argon. To prepare control liposomes POPC and POPE were mixed in a 90:10 molar ratio, for BLiTz experiments liposomes were doped with 0.5% biotinylated POPE. Liposomes containing phosphoinositides were prepared by mixing POPC, POPE and PIPs in a 80:10:10 molar ratio respectively. 30% POPS was used for POPC:POPE:POPS. Dried lipids were hydrated in 25 mM HEPES (pH 7.2), and 220 mM sucrose to obtain a suspension of multilamellar liposomes containing sucrose. This solution was then freeze-thawed five times to produce unilamellar liposomes. Liposomes were then diluted 1:5 in 25 mM HEPES (pH 7.2), and 125 mM NaCl solution. The solution was then centrifuged at 250,000 g to remove sucrose from the medium and maintain osmolarity. The pelleted liposomes were resuspended in 25 mM HEPES (pH 7.2), and 125 mM NaCl solution to the desired concentration of 0.5 mM. All liposomes were used within 1 day of preparation.

Liposome pelleting {#s4-11}
------------------

10 µM of the protein of interest was added to a final volume of 200 µl of the liposome solution. This solution was left at room temperature for 25 min to allow for protein-liposome interaction. After incubation, the solution was centrifuged at 400,000 g for 30 min. Supernatant and pellet fractions were separated and the pellet was resuspended in 200 µl of 25 mM HEPES (pH 7.2), and 125 mM NaCl, samples were then collected for analysis on a precast 4--12% bis-tris gel (Novex) by coomassie staining.

Biophysical interaction using Bio-layer interferometry (BLiTz) {#s4-12}
--------------------------------------------------------------

Protein-lipid and protein-protein interactions were determined using the bio-layer interferometry from the BLiTz system. Protein-lipid interactions were observed by immobilizing 500 µM of biotinylated liposomes on a streptavidin biosensor. After immobilization, the sensor was washed with buffer containing 10 mM Tris (pH 8.0), 150 mM NaCl and 0.1% BSA to prevent non-specific association. Increasing concentrations (12.5, 25, 50 and 100 µM) of protein were added to the sensor and the change in binding (nm) was measured. Proteins were then allowed to disassociate from the probe in the buffer previously mentioned. The kinetics of the protein-protein interactions were determined in the same fashion using 5 µM of His-tagged COMMD1 COMM domain immobilized on a nickel-NTA probe and increasing protein concentrations of 62.5, 125, 250 and 500 µM. The data was processed and plotted using the Sigmaplot package (Systat Software Inc.).

Cell culture {#s4-13}
------------

RPE1, HEK293T cells were maintained in DMEM (D5796; Sigma-Aldrich) plus 10% fetal calf serum (F7524; Sigma-Aldrich) under standard conditions. These cell lines were obtained from America Type Culture Collection (ATCC). Parental and stable cells lines were negative for mycoplasma by DAPI staining, and authenticated by STR profiling. Lentivirus particles for producing stably expressing cell lines were generated in HEK293T cells using the pXLG3 vector to carry the GFP tagged Commd1 WT and Commd1 (R133Q, H134A, K167A). Cells were transfected with DNA using polyethylenimine (Sigma-Aldrich). Virus was harvested from the growth media 72 hr post transfection.

For stable transduction with lentivirus, cells were seeded at 75,000 per well in six well plates. The cells were then incubated under normal conditions with titrations of viral supernatant for 72 hr. Cells were then passaged and expression of the GFP tagged protein of interest assessed by western analysis. Cell lines that displayed similar expression levels were selected for comparison and those closest to endogenous levels of protein.

Immunofluorescence {#s4-14}
------------------

RPE1 cells grown on 13 mm coverslips were washed with PBS before being fixed in ice cold 4% formaldehyde in PBS for 25 min. Cells were permeabilised in 0.1% Triton X-100 (Sigma) for 6 min. The cells were then blocked with 1% bovine serum albumin (BSA) in 0.01% Triton for 15 min at room temperature. Primary antibodies were diluted in 1% BSA and samples were incubated for 1 hr at room temperature. The samples were then incubated with Alexa Fluor conjugated secondary antibody and 0.2 µM DAPI for 30 min at room temperature. Coverslips were mounted in Mowiol-DABCO mounting medium (Sigma). Cells were visualised using a Leica TCS SP5 X confocal microscope (Leica Biosystems).

Data availablity {#s4-15}
----------------

Coordinates and structure factors for the COMM and HN domain of Commd9 have been deposited at the Protein Data Bank (PDB) with accession codes 6BP6 (COMM domain Commd9) and 4OE9 (HN domain of Commd9).
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Decision letter

Munro

Sean

Reviewing Editor

MRC Laboratory of Molecular Biology, Cambridge

United Kingdom

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Structural insights into the architecture and membrane interactions of the conserved COMMD proteins\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Vivek Malhotra as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers are in broad agreement that the COMMD proteins have an important, if enigmatic, role in endosome function and that insight into their structure will help underpin studies aimed an better understanding this role. However, there is a concern that the biological significance of the structural data presented is not fully established. Such insight would be expected for a broad interest journal such as *eLife*. The reviewers have suggested that this could be addressed by using the structure to identify COMMD residues that are involved in binding CCDC22 and/or CCDC93.

If you feel that you can add this further experimental work, or carry out related experiments to address the same point, then we would be happy to consider a revised version. If you submit a revision, please tend to other aspects of the experimental work that need attention.

Summary:

COMMD proteins comprise a highly conserved eukaryotic protein family. Its 10 members in human are implicated in cellular trafficking and the regulation of transcription. The proteins consists of an N-terminal calponin homology-like domain (HN) and a C-terminal COMM domain. To understand the molecular basis for its function, the authors of this study determined the crystal structure of the isolated COMM and HN domain of COMMD9. They found that COMM domains form homo- and heteromeric assemblies via a highly conserved interface, whereas the HN domain is monomeric. SAXS measurements with the full-length constructs of Commd1, Commd7 and Commd9 were used to extract information on the quaternary assembly. Using pull-down studies, gel filtration analysis and Blitz measurements, they further characterized heteroassembly of COMMDs within the family and with the CCC components CCDC22 and 93. Finally, they found unspecific membrane-binding of Commd 10 to liposomes of various compositions. Mutations of a basic patch in Commd10 reduced membrane binding but not its cellular localization on endosomal structures.

Essential revisions:

1\) COMMD homo- and heterodimers:

Homo- and heterodimerization seems to be promiscuous among Commd proteins. While Commd1, Commd7 and Commd9 behave as 1/1 homodimers (Figure 1A), the Commd5-Commd10 complex behaves as a 2/2 heterotetramer (Figure 7E). From Figure 7A, it seems that by co-expression in *E. coli*, Commd10 binds strongly to Commd2. Is heterotetramerization also applicable to Commd10- Commd2 complex?. Is tetramerization a property of heterodimers?.

2\) COMMD-CCC interactions:

COMMD domains of Commd1, Commd7 and Commd10 interact directly with the NN-CH domain of CCD22 and CCDC93 whereas Commd9 binds specifically to CCDC93 (Figure 8). The crystal structure of COMMD9 presented in this work and the homology model of COMMD1 (Figure 9B) should facilitate the identification of a similar surface patch, distinct from the conserved dimerization core, responsible for binding to the NN-CH domain of CCDC93. Authors could exploit this structural information together with site-directed mutagenesis and bio-layer interferometry as shown in Figure 8C, D to identify and confirm the binding interface. This would add a great value to the present work.

3\) Membrane association:

The basic patch (K129, R133, H134, K167) identified in COMM1 that is important for interaction with model membranes, is not conserved in Commd7 or Commd10, which also interact with membranes (Figure 9A). Furthermore, this patch is neither conserved in other Commd members (Figure 3B) suggesting a singular and partial mechanism only applicable to Comm1. How other Commd complexes, dimers or heterodimers, are recruited to the membrane remain unknown. One possibility for membrane recruitment might be through interaction with the CCC complex but exploring this possibility would require the identification of the conserved patch in COMMD proteins for binding to CCDC22 and/or CCDC93.

4\) Figure 5: The graphs on top are too small to recognize anything. More importantly, the scattering curves and the resulting envelopes look very similar. Given the ambiguities in fitting such low resolution envelopes, the authors should not make any firm conclusions on the details of the assemblies, since they are most likely wrong. The firm conclusions of these measurements appear to be: Homomeric COMMDs form a dimer in SAXS. In some likelihood, the COMMD domains are in the center whereas the HN domains are at the periphery.. the authors are recommended to tone down the conclusions of different assemblies and maybe only show data and the model of Commd9 in the main manuscript.

5\) Figure 7A: Commd8: There is hardly any protein of the correct size in the Commassie gel, and it appears even unclear whether the proposed band is at all related to COMM8. Strangely enough, this protein still interacts with high efficiency with all Commd proteins. That does not make much sense: Either improve or remove.

6\) Figure 8A: Again, hardly any CCDC22 full length is expressed and a strong interaction with COMM1 is observed (both with the N- and C-terminal domains of CCDC22 -- the authors should also comment on this in the main manuscript). Furthermore, COMM1 also appears to be partly pulled down by GST. This is worrisome, there seems to be an unspecific binding of COMM1 to almost anything and the data for CCDC22 are uninterpretable. These experiments should be improved, for example with more stringent washing conditions or finding better expression conditions.

7\) The structural homology analysis of COMMD proteins to Pur-α, CT584 and Cpn0803, do not contribute much to the overall story and are distractive. In this sense, the homology only hints at a shared fold for dimerization but there is no support for functional similarities to Pur-α, or mimicking function by the chlamydial proteins. This section might be shortened and/or incorporated into supplementary material.

8\) The liposome binding experiments appear to lack a negative control -- i.e. liposomes that are not acidic such as those of pure PC.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Structural insights into the architecture and membrane interactions of the conserved COMMD proteins\" for further consideration at *eLife*. Your revised article has been favorably evaluated by a Senior Editor and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues about the text that the reviewers agree need to be addressed before acceptance, as outlined below:

1\) In the summary the authors make a claim on defining the core principles of Commd homo- and heteromeric assembly. This is clearly an overstated claim as the interaction between Commd proteins seems to be quite promiscuous and still there are no clear principles of how homodimer-versus-heterodimer preference is achieved.

2\) Crosslinking data: The WRVD motif should be better introduced. The cross-linked results are interesting and narrow down the potential interface between Commd9 and CCDC93, yet the proposed WRVD motif seems to be part of the conserved dimerisation core (Figure 2). Based on the calponin homology domain of CCDC93, the structure of Commd9, the BS3 cross linking distance, and conserved residues on the surface, authors should be able to propose a plausible contact area in Commd9 despite the NMR unfruitful results.

3\) Figure 4: I am still not happy to see three different molecular models for full length Commd1, Commd7 and Commd9. It\'s just misleading, the envelopes look all the same. One representative model showing that the COMMD and HN domain fit into all envelopes would be completely sufficient and less confusing.

4\) Following our initial advice, Figure 5 should go to the supplement.

5\) Typo: subsection "COMM domain binds to CCDC22 and CCDC93 through a conserved motif", first paragraph -- should be K133, not K131 (K131 is the residue in CCDC93).

6\) Subsection "COMM domain binds to CCDC22 and CCDC93 through a conserved motif" -- is missing a full stop.

7\) Figure 3---figure supplement 1: aa numbers 151 to 200 are missing.

8\) Figure 7 legend: Description for panel D is missing (CCDC93 interaction).

I hope that addressing these points will not be difficult for you. If you can provide a point-by-point summary of the changes you have made I should be able to make a final decision without having to consult the reviewers again.

10.7554/eLife.35898.032

Author response

> Essential revisions:
>
> 1\) COMMD homo- and heterodimers:
>
> Homo- and heterodimerization seems to be promiscuous among Commd proteins. While Commd1, Commd7 and Commd9 behave as 1/1 homodimers (Figure 1A), the Commd5-Commd10 complex behaves as a 2/2 heterotetramer (Figure 7E). From Figure 7A, it seems that by co-expression in E. coli, Commd10 binds strongly to Commd2. Is heterotetramerization also applicable to Commd10- Commd2 complex?. Is tetramerization a property of heterodimers?.

The reviewers correctly observed that among the promiscuous Commd-Commd interactions we detect, Commd10 appears to bind strongly to Commd2. We have been able to reconstitute this complex (see [Author response image 1](#respfig1){ref-type="fig"}), however due to poor yield we have not been able to conduct MALS experiments to determine the precise oligomeric state. Interestingly, this heterodimer does not appear to be a 1:1 complex on gels, although we can't yet be sure until we improve the purification protocols. We therefore believe that Commd10-Commd2 can behave in a similar manner to the Commd10-Commd5 complex, but we can\'t yet state if tetramerisation is a common property.

![Commd2-Commd10 co-purification.\
GST-Commd2 was co-expressed with Commd9-His, proteins were then purified by GST-affinity chromatography, thrombin cleavage and then His-tag affinity chromatography. The two proteins co-purify in a stable heterodimer (Commd10-His is the upper band and cleaved Commd2 is the lower band.](elife-35898-resp-fig1){#respfig1}

> 2\) COMMD-CCC interactions:
>
> COMMD domains of Commd1, Commd7 and Commd10 interact directly with the NN-CH domain of CCD22 and CCDC93 whereas Commd9 binds specifically to CCDC93 (Figure 8). The crystal structure of COMMD9 presented in this work and the homology model of COMMD1 (Figure 9B) should facilitate the identification of a similar surface patch, distinct from the conserved dimerization core, responsible for binding to the NN-CH domain of CCDC93. Authors could exploit this structural information together with site-directed mutagenesis and bio-layer interferometry as shown in Figure 8C, D to identify and confirm the binding interface. This would add a great value to the present work.

This is an excellent suggestion and we have attempted to define the interface on Commd9 that is coordinating the interaction with NN-CH domain of CCDC93 using cross-linking mass spectrometry. This new data together with text has been included in the revised manuscript. While this data now identifies a region on the Commd9 COMM domain that is involved in binding to the CCDC93 CC-NH, we have not been able to discover a point mutant that blocks this interaction based on this information. Until we are able to determine a high-resolution structure of the complex between the two proteins we would argue that this is likely just because XL-MS is unable to define the process side-chains required for binding.

We also attempted to use NMR to test whether it is possible to assign the backbone of the Commd9 COMM domain for titration mapping experiments with NN-CH domains of CCDC22 and CCDC93. However, the NMR spectra in the conditions tested did not give ^15^N HSQC spectra that can be used for such experiments.

These data are included in the new Figure 8, the previous Figure 8 is now Figure 7.

> 3\) Membrane association:
>
> The basic patch (K129, R133, H134, K167) identified in COMM1 that is important for interaction with model membranes, is not conserved in Commd7 or Commd10, which also interact with membranes (Figure 9A). Furthermore, this patch is neither conserved in other Commd members (Figure 3B) suggesting a singular and partial mechanism only applicable to Comm1. How other Commd complexes, dimers or heterodimers, are recruited to the membrane remain unknown. One possibility for membrane recruitment might be through interaction with the CCC complex but exploring this possibility would require the identification of the conserved patch in COMMD proteins for binding to CCDC22 and/or CCDC93.

We agree that it is currently not clear how various members of the COMMD family tether to the membranes. Indeed as our data for Commd1 shows, although it can bind membranes this doesn't appear to be essential for specific endosomal localization. We actually debated showing this negative data, but eventually felt it was important to show this for completeness. Although speculation, we think that the avidity effect provided by all of the COMMD members and perhaps through direct interaction of other CCC components with membranes and membrane-associated proteins will prove to be key determinants for endosomal recruitment. As discussed above although we now have used XL-MS to gain an insight into the interaction region of Commd9 with CCDC proteins, we are not yet able to generate specific mutants that perturb these interactions to determine the importance in membrane recruitment.

> 4\) Figure 5: The graphs on top are too small to recognize anything. More importantly, the scattering curves and the resulting envelopes look very similar. Given the ambiguities in fitting such low resolution envelopes, the authors should not make any firm conclusions on the details of the assemblies, since they are most likely wrong. The firm conclusions of these measurements appear to be: Homomeric COMMDs form a dimer in SAXS. In some likelihood, the COMMD domains are in the center whereas the HN domains are at the periphery.. the authors are recommended to tone down the conclusions of different assemblies and maybe only show data and the model of Commd9 in the main manuscript.

This figure has been made larger to more clearly show the data. We have also changed the language in the text to suggest that SAXS data confirms the MALLS and crystallography data that COMMD proteins are homodimers in solution. We agree that bold interpretations cannot be made from the scattering experiments, however at the least the data clearly shows the overall shape of various COMMD proteins, and confirms their homodimeric nature. Therefore, we have for now opted to keep all of the SAXS data in this revised version.

The old Figure 5 is now replaced with Figure 4.

> 5\) Figure 7A: Commd8: There is hardly any protein of the correct size in the Commassie gel, and it appears even unclear whether the proposed band is at all related to COMM8. Strangely enough, this protein still interacts with high efficiency with all Commd proteins. That does not make much sense: Either improve or remove.

GST-Commd8 has a tendency to degrade over time, but we have identified through time course experiments that the marked band is indeed GST fused Commd8. The protein appears to be binding other Commd proteins and fragments, as seen in the western blotting-based detection method we have employed that is quite sensitive. However, on the advice of reviewers we have removed this data for Commd8.

Figure 7 has been changed to Figure 6 due to merging of Figure 1 and 2.

> 6\) Figure 8A: Again, hardly any CCDC22 full length is expressed and a strong interaction with COMM1 is observed (both with the N- and C-terminal domains of CCDC22 -- the authors should also comment on this in the main manuscript). Furthermore, COMM1 also appears to be partly pulled down by GST. This is worrisome, there seems to be an unspecific binding of COMM1 to almost anything and the data for CCDC22 are uninterpretable. These experiments should be improved, for example with more stringent washing conditions or finding better expression conditions.

New text describing the interactions of COMM domains with both HN and COMM domain has been included in the manuscript. With regards to the full length CCDC22 protein band, like Commd8, CCDC22 also has a tendency to degrade in to smaller fragments. However, there is still some fraction of intact GST fused CCDC22 visible on the Coomassie stained gel as shown by the asterisk and since the detection method is very sensitive, we can still detect an interaction band.

We have also repeated the pull down again and have included the new blot in the revised manuscript. In this new round, the non-specific GST binding has been reduced and comparison with other bands on the gel clearly shows that the interaction to CCDC proteins is specific. We also note that GST is expressed heavily compared to the other bait proteins.

Please note, Figure 8 is now Figure 7.

> 7\) The structural homology analysis of COMMD proteins to Pur-α, CT584 and Cpn0803, do not contribute much to the overall story and are distractive. In this sense, the homology only hints at a shared fold for dimerization but there is no support for functional similarities to Pur-α, or mimicking function by the chlamydial proteins. This section might be shortened and/or incorporated into supplementary material.

We have truncated this section in the text.

> 8\) The liposome binding experiments appear to lack a negative control -- i.e. liposomes that are not acidic such as those of pure PC.

We have now included the data containing PC as a negative control.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues about the text that the reviewers agree need to be addressed before acceptance, as outlined below:
>
> 1\) In the summary the authors make a claim on defining the core principles of Commd homo- and heteromeric assembly. This is clearly an overstated claim as the interaction between Commd proteins seems to be quite promiscuous and still there are no clear principles of how homodimer-versus-heterodimer preference is achieved.

We have toned down this statement in the summary to "Here, we have systematically characterised the interactions between several human COMMD proteins, and determined structures of COMMD proteins using X-ray crystallography and X-ray scattering to provide insights into the underlying mechanisms of homo- and heteromeric assembly." We agree that our data still cannot provide a concise explanation for why specific homo and heterodimers are formed, but it does reveal new insights into how these interactions occur.

> 2\) Crosslinking data: The WRVD motif should be better introduced. The cross-linked results are interesting and narrow down the potential interface between Commd9 and CCDC93, yet the proposed WRVD motif seems to be part of the conserved dimerisation core (Figure 2). Based on the calponin homology domain of CCDC93, the structure of Commd9, the BS3 cross linking distance, and conserved residues on the surface, authors should be able to propose a plausible contact area in Commd9 despite the NMR unfruitful results.

We apologise that this was not described clearly enough. We have now modified the text and also Figure 7 showing the sites of lysine cross-linking to better explain our finding. What we observe is that the two major sites of lysine cross-linking in the Commd9 COMM domain are part of a contiguous surface, and that this surface also includes the residues from the conserved sequence ^128^WRVD^131^. The strictly conserved Trp128 in particular does make key contacts that appear to be required for COMM domain dimerization. But, unusually for a Trp side-chain, it is also surface exposed, suggesting it may be part of a binding surface for the CCDC93 NN-CH domain. However, we did not want to speculate too much based on our data and have therefore modified the text as follows:

"Notably, K133 and K152 are located on contiguous surfaces of the β-sheets of the COMM domains (Figure 7D), suggesting a likely binding surface for the CCDC93 NN-CH domain. This surface also includes the side-chains of the conserved residues ^128^WRVD^131^, with Trp128 in particular being strictly conserved across the entire Commd family (Figure 2B)."

> 3\) Figure 4: I am still not happy to see three different molecular models for full length Commd1, Commd7 and Commd9. It\'s just misleading, the envelopes look all the same. One representative model showing that the COMMD and HN domain fit into all envelopes would be completely sufficient and less confusing.

We have removed the data showing the SAXS-derived solution structures of Commd1 and Commd7 into Figure 4---figure supplement 2, and retained only the SAXS-derived solution structure of Commd9 in the main text for clarity. We hope this satisfies the reviewer's concerns.

> 4\) Following our initial advice, Figure 5 should go to the supplement.

Figure 5 has now been moved to Figure 4---figure supplement 4. Subsequent figures have been renumbered accordingly, and figure citations in the text have been modified to reflect the changes.

> 5\) Typo: subsection "COMM domain binds to CCDC22 and CCDC93 through a conserved motif", first paragraph -- should be K133, not K131 (K131 is the residue in CCDC93).

This has been corrected.

> 6\) Subsection "COMM domain binds to CCDC22 and CCDC93 through a conserved motif" -- is missing a full stop.

This has been corrected.

> 7\) Figure 3---figure supplement 1: aa numbers 151 to 200 are missing.

This has been corrected.

> 8\) Figure 7 legend: Description for panel D is missing (CCDC93 interaction).

This has been corrected.

[^1]: Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, United Kingdom.
